Clinical Trials Browser

Phase 2 × Anti-Bacterial Agents × Thoracic × Clear all

NCT05502913 2023-10-02

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

Phase 2 Recruiting

Lung Neoplasms

NCT00932152 2017-10-19

Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

Phase 2 Terminated

3 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung